The efficacy and safety of dual-pathway inhibition therapy among patients with peripheral arterial disease - a meta-analysis
Event: ESC Congress 2021 - The Digital Experience
Topic: Treatment
Session: Peripheral Vascular and Cerebrovascular Disease ePosters
ESC 365 is supported by
